Last updated: August 8, 2022
Sponsor: Shanghai Zhongshan Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Coronary Artery Disease
Myocardial Ischemia
Atherosclerosis
Treatment
N/AClinical Study ID
NCT05496023
ZS20220808
CHART2022-04
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- any patient meets eligible criteria who underwent PCI with DES followed by invasivephysiologic assessment at the index procedure
- any patient who underwent PCI for lesions with pre-PCI FFR<=0.80
- available of both pre- and post-PCI FFR measurement
- available of both pre- and post-PCI angio-FFR calculation
- available of pre-PCI co-registration of angio-FFR with coronary angiogram
Exclusion
Exclusion Criteria:
- unavailable pre-PCI angio-FFR calculation and co-registration with coronary angiogram
- unavailable post-PCI angio-FFR calculation
- culprit vessel of acute coronary syndrome
- failed achieving TIMI 3 flow at the end of PCI
- left ventricular ejection fraction <30%
- graft vessel
- collateral feeder
- in-stent restenosis
- primary myocardial or valvular heart disease
- in patient whose life expectancy less than 2 years
- visible thrombus of target vessel segment
Study Design
Total Participants: 329
Study Start date:
January 01, 2017
Estimated Completion Date:
October 01, 2022
Study Description
Connect with a study center
Zhongshan Hospital of Fudan University
Shanghai, 200032
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.